within Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P03A_EctoparasiticidesInclScabicides.P03AX03_Malathion;

model Malathion
  extends Pharmacolibrary.Drugs.ATC.P.P03AX03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>P03AX03</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Malathion is an organophosphate insecticide used for the treatment of head lice and body lice infestations in humans, as well as for mosquito control in public health. It acts as an acetylcholinesterase inhibitor. While it was previously used in agriculture and in public health vector control, in medical settings it is primarily available in topical formulations for lice treatment. Use in humans is limited to topical application; oral or systemic use is not approved due to toxicity.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetics for malathion in adult humans following topical administration; actual human systemic exposure after topical use is extremely low, with absorption <10%. No published human PK model.</p><h4>References</h4><ol><li><p>Deeks, LS, et al., &amp; Bowden, FJ (2013). Topical ivermectin 0.5% lotion for treatment of head lice. <i>The Annals of pharmacotherapy</i> 47(9) 1161–1167. DOI:<a href=\"https://doi.org/10.1177/1060028013500645\">10.1177/1060028013500645</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24259731/\">https://pubmed.ncbi.nlm.nih.gov/24259731</a></p></li><li><p>Villegas, SC, &amp; Breitzka, RL (2012). Head lice and the use of spinosad. <i>Clinical therapeutics</i> 34(1) 14–23. DOI:<a href=\"https://doi.org/10.1016/j.clinthera.2011.11.026\">10.1016/j.clinthera.2011.11.026</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22177544/\">https://pubmed.ncbi.nlm.nih.gov/22177544</a></p></li><li><p>Bucks, DA, et al., &amp; Maibach, HI (1985). Percutaneous absorption of malathion in the guinea-pig: effect of repeated topical application. <i>Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association</i> 23(10) 919–922. DOI:<a href=\"https://doi.org/10.1016/0278-6915(85)90108-5\">10.1016/0278-6915(85)90108-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/4065766/\">https://pubmed.ncbi.nlm.nih.gov/4065766</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Malathion;
